Gastrointestinal Stromal Tumors (GIST) Pipeline Analysis 2018 - Focusing On Clinical Trials And Results, Drug Profiling, Patents, Collaborations, And Other Recent Developments
- Published : Mar 2020
- Report Code : KSI061611436
- Pages : 114
Offered with this report
Market Data and Estimates in Excel
2 Months of Post Sale Analyst Support
Requirement Specific Customization
Gastrointestinal stromal tumors (GIST) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.
Gastrointestinal stromal tumors (GIST) Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Gastrointestinal stromal tumours (GIST) are the rare tumors associated with the gastrointestinal (GI) tract. The beginning of the tumors starts in the interstitial cells of Cajal (ICCs) which help in the regulation of the digestion processes in the body. They are also referred to as the pacemakers of the GI tract. The tumours can spread to the other parts of the body as well.
The report provides Gastrointestinal stromal tumors (GIST) treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Arog Pharmaceuticals, Inc., Blueprint Medicines Corporation, Calithera and Ascentage Pharma among others.
Scope:
- By Company
- By Phase
- By Molecule Type
- By Region
- By Route of Administration
1. Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region
2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
• Drug Name
• Generic Name
• Synonyms
• Company
• Collaborator
• Route of administration
• Target
• Mechanism of Action
• Technology
• Molecule type
• CAS Number
• Weight
• Chemical Formula
• IUPAC name
• ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6. Company profiling
6.1. Array BioPharma
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.2. Plexxikon
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. AB SCIENCE
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. Immunicum AB
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. Deciphera Pharmaceuticals, Inc.
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.6. Arog Pharmaceuticals, Inc
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.7. Boston Biomedical
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.8. ArQule
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.9. Ascentage Pharma
6.9.1. Introduction
6.9.2. Financials
6.9.3. Products and Services
6.9.4. SWOT
6.10. Blueprint Medicines Corporation
6.10.1. Introduction
6.10.2. Financials
6.10.3. Products and Services
6.10.4. SWOT
6.11. Calithera
6.11.1. Introduction
6.11.2. Financials
6.11.3. Products and Services
6.11.4. SWOT
6.12. Celldex Therapeutics
6.12.1. Introduction
6.12.2. Financials
6.12.3. Products and Services
6.12.4. SWOT
List of Tables
List of Figures
Plexxikon
AB SCIENCE
Immunicum AB
Deciphera Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc
Boston Biomedical
ArQule
Ascentage Pharma
Blueprint Medicines Corporation
Calithera
Celldex Therapeutics
Related Reports
| Report Name | Published Month | Get Sample PDF |
|---|---|---|
| Industrial Enzymes Market Share & Trends: Report, 2024-2029 | Mar 2024 | |
| Modular Data Center Market Size: Industry Report, 2024-2029 | Mar 2024 | |
| Fluorochemicals Market Size, Share, & Growth: Report, 2024-2029 | Mar 2024 | |
| E-Cigarettes Market Size, Share & Growth: Report, 2024-2029 | Mar 2024 | |
| Tissue Diagnostic Market Size & Share: Industry Report, 2023-2028 | Aug 2023 |